Western Europe
PLEASANTON, California, December 16, 2011 -
- The test confidently detects HLA-B*5701 to help decrease risk of abacavir hypersensitivity reaction
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its HLA-B*5701 screening test[1] is now commercially available in Europe.
SEOUL, South Korea, December 6, 2011 -
World Cyber Games, Inc.
SANTIAGO, Chile, November 25, 2011 -
Agriculture has historically been one of the pillars of the Chilean economy.
ArKay Beverages, Inc. Is In Compliance With the Packaging and Advertising Laws of the European Union
FORT LAUDERDALE, Florida, November 21, 2011 -
It has come to our attention that the Scotch Whisky Association (SWA) has been making allegations and inaccurate statements to the media concerning ArKay Beverages.
COLOGNE, Germany, November 15, 2011 -
Acentic, a leading supplier of broadband systems and digital interactive TV (iTV) for the hotel industry, has announced that it has joined Hotel Technology Next Generation (HTNG), a global trade association dedicated to enhancing the deployment of technology in hotels.
More News
- Abbott Receives CE Mark for New Hepatitis Test
- Nissan Accelerates Roll Out of EV Quick Charge Network in Europe
- Industry Leaders Create EarthMinded Life Cycle Services
- Oberthur Technologies Associates With Valitor and Visa Europe for Iceland’s First Mobile Payments Project
- TeliaSonera Make Mobile Surfing Easier in Europe
- ‘Youth in Europe’ Drug Prevention Programme Sees Youth Drinking Drop From 42% to 9%
- Icelandic President to Make History by Leading the Nation to Open Homes to Tourists
- ChipSiP Unveils Cutting-edge SiP Solutions to Experience an Unlimited Sharing Life
- Verne Global Opens World’s First Dual-Sourced 100% Renewably Powered Data Centre
- Datapipe Partners with Verne Global to Deliver Green Cloud from Iceland
- The National Energy Authority of Iceland (NEA), has Today, October 3, 2011, Announced the Second Licensing Round for Hydrocarbon Exploration and Production Licenses on the Icelandic Continental Shelf
- ALIMTA Receives Positive Opinion From CHMP as Continuation Maintenance Therapy for a Fatal Form of Lung Cancer
- Save the Whales Again! Campaign Spokesperson Hayden Panettiere Personally Thanks President Obama for his Bold Actions to Stop Iceland’s Whaling
- Transact Network Reaches Half a Million Prepaid Card Milestone With MasterCard
- Naviscan Receives CE Mark Approval for High-Resolution Breast PET and PET-Guided Biopsy
- Redknee Expands Strategic Partnership With Tier 1 Western European Operator
- Voyages Jules Verne Launches Latest World of Wonders
- Save the Whales Again! Campaign Spokesperson Hayden Panettiere Applauds President Obama for Condemning Iceland’s Whaling
- Firth Rixson, Snecma Reach Closed Die Forgings Agreement
- SAND Announces Partnership with Uniserv
- Digital Life Academy Announces Members for the 2011 Session
- ViroPharma’s Cinryze (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
- DNA Sequencing Data Reveals New Hybrid E. coli Strain is Cause of German Outbreak
- Animas(R) Vibe(TM), the First Integrated Offering from Animas Corporation and Dexcom, Inc., Receives European CE Mark Approval
- Zimmer Features Trabecular Metal(TM) Augment Shapes and Cones for Knee Revision Surgery at EFORT Congress
- No Dis-eruption Here: Park Resorts Confirm Their Caravan Parks Free From Grimsvotn's Ash Cloud
- New Research Reveals Data Centre Expansion a Priority for European Businesses
- Abbott Receives CE Mark for its RealTime Molecular Test for Cytomegalovirus
- Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
- Accumetrics' Platelet Reactivity Test Achieves CE Marking for Identifying Patients at Greater Risk of Recurrent Cardiovascular Events
- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION
- This Recognition of Clinical Benefits Across Europe is Supported by Five-Year Outcomes for Low-Risk Prostate Cancer Patients Treated in Five Sessions
- UK, France and Germany lead the recovery, while Spain and Italy lag
- "Proven" and "Soft" Claims Continue to Dominate in EU - Top Ten Health Trends
- Absorbable Bone Hemostat Matrix Cleared For Clinical Use and Sale in Europe and Canada
